needed effects
emtricitabine
tenofovir
unwanted side effects
medical attention
following side effects
taking emtricitabine
tenofovir
check
doctor
emtricitabine
tenofovir side effects
medical attention
body
medicine
side effects
health care professional
side effects
following side effects
side effects
emtricitabine
tenofovir disoproxil fumarate
df
combination with other antiretroviral agents
common side effects
hiv
infected patients during a clinical study of efavirenz
emtricitabine
tenofovir df
diarrhea
nausea
fatigue
headache
dizziness
depression
insomnia
abnormal dreams
rash
trial
emtricitabine-tenofovir df
efavirenz
weeks
replacing emtricitabine
tenofovir df
efavirenz
hiv
uninfected individuals in preexposure prophylaxis trials
common side effects
emtricitabine-tenofovir df
headache
abdominal pain
weight
emtricitabine-tenofovir df
increased fasting cholesterol
decreased phosphorus
fasting triglycerides
altered serum glucose
weight loss
hyperglycemia
alkaline phosphataseemtricitabine
tenofovir alafenamide
frequency
increased total cholesterol
low-density lipoprotein
ldl
cholesterol
high-density lipoprotein
hdl
cholesterol
triglyceridesemtricitabine
hyperglycemia
hypertriglyceridemia
serum glucose-frequency
lactic acidosistenofovir df
hypophosphatemia
anorexia
weight loss
serum glucose-uncommon
hypokalemia-rare
lactic acidosisantiretroviral therapy
frequency
redistribution/accumulation of body fat
including
central obesity
dorsocervical fat enlargement
peripheral wasting
facial wasting
breast enlargement
cushingoid appearance
increased blood lipid levels
glucose levels
increased fasting cholesterol
mg/dl
phosphorus
lower limit of normal
mg/dl
fasting triglycerides
mg/dl
altered serum glucose
mg/dl
mg/dl
hyperglycemia
mg/dl
alkaline phosphatase
units/l
emtricitabine-tenofovir df
clinical trials
following mean increases
antiretroviral therapy-naive patients
using emtricitabine
tenofovir alafenamide with elvitegravir
cobicistat for weeks
total cholesterol
mg/dl
ldl cholesterol by mg/dl
hdl cholesterol by mg/dl
triglycerides by mg/dl
lactic acidosis
steatosis
including
fatal cases
use of nucleoside analogs
hypokalemia
hypophosphatemia
result of proximal renal tubulopathy
hypokalemia
lactic acidosis
hypophosphatemia
postmarketing experience with tenofovir df
increased ast
times
upper limit of normal
uln
uln
alt
uln
uln
bilirubin
uln
emtricitabine-tenofovir df
increased ast
units/l
alt
units/l
males
using emtricitabine-tenofovir df
increased ast
units/l
alt
units/l
females
using emtricitabine-tenofovir df
severe acute exacerbations of hepatitis
patients with hepatitis b after discontinuation of this drug
liver failure
liver decompensation in some emtricitabine-treated patients
lactic acidosis
steatosis
including
fatal cases
use of nucleoside analogs
hepatic steatosis
hepatitis
postmarketing experience with tenofovir df
emtricitabine-tenofovir df
increased ast
alt
increased bilirubin-frequency
severe acute exacerbations of hepatitis bemtricitabine
increased serum ast
increased serum alt
hyperbilirubinemia-frequency
liver failure
liver decompensationtenofovir df
increased transaminases
ast
alt
hepatic steatosis
hepatitis-frequency
lactic acidosis/severe hepatomegaly with steatosis-postmarketing reports
increased liver enzymes
ast
alt
ggt
decreased neutrophils
mm
mm
hemoglobin
mg/dl
mg/dl
emtricitabine-tenofovir df
emtricitabine-tenofovir df
decreased neutrophils
decreased hemoglobinemtricitabine
neutropenia-uncommon
anemiatenofovir df
decreased neutrophils
emtricitabine-tenofovir df
pharyngitis
sinusitis
upper respiratory tract infections
nasopharyngitisemtricitabine
tenofovir df
increased cough
pneumonia
rhinitisemtricitabine
rhinitis
coughtenofovir df
pneumonia-postmarketing reports
dyspnea
increased serum amylase
units/l
pancreatic amylase
uln
serum lipase
uln
emtricitabine-tenofovir df
clinical trials
nausea
common side effect
antiretroviral therapy-naive hiv
infected patients
using emtricitabine
tenofovir alafenamide with elvitegravir
cobicistat
pancreatitis
abdominal pain
amylase
postmarketing experience with tenofovir df
emtricitabine-tenofovir df
diarrhea
nausea
serum amylase
abdominal pain
pancreatic amylase
serum lipase
vomiting-frequency
flatulenceemtricitabine
tenofovir alafenamide
nauseaemtricitabine
tenofovir df
dyspepsia
abdominal painemtricitabine
diarrhea
nausea
abdominal pain-common
increased amylase
including
increased pancreatic amylase
serum lipase
vomiting
dyspepsiatenofovir df
diarrhea
vomiting
abdominal pain
abdominal distension
flatulence
dyspepsia
serum
pancreatitis
emtricitabine-tenofovir df
depression
insomnia
abnormal dreams
anxietyemtricitabine
tenofovir df
anxietyemtricitabine
insomnia
abnormal dreams-common
depressive disorderstenofovir df
insomnia
anxiety
emtricitabine-tenofovir df
dizziness
headache-frequency
somnolenceemtricitabine
tenofovir df
peripheral neuropathy
including neuropathy
peripheral neuritis
paresthesiaemtricitabine
dizziness
neuropathy/peripheral neuritis
paresthesiatenofovir df
dizziness
peripheral neuropathy
including neuropathy
peripheral neuritis
asthenia
postmarketing experience with tenofovir df
emtricitabine-tenofovir df
fatigue
syphilis
secondary syphilisemtricitabine
tenofovir df
pain
feveremtricitabine
asthenia-common
paintenofovir df
pain
chest pain
fever-frequency
vitamin d levelsantiretroviral therapy
frequency
increased weight
emtricitabine-tenofovir df
rash event
including rash
maculopapular rash
exfoliative rash
generalized rash
macular rash
pruritic rash
vesicular rash
emtricitabine
rash event
including rash
pruritus
maculopapular rash
urticaria
vesiculobullous rash
pustular rash
allergic reaction
skin discoloration
palmar-plantar hyperpigmentation
frequency
lipodystrophy-postmarketing reports
angioedematenofovir df
rash event
including rash
pruritus
maculopapular rash
urticaria
vesiculobullous rash
pustular rash
sweating-uncommon
lipodystrophy-rare
angioedema
rash
postmarketing experience with tenofovir df
increased creatine kinase
males
units/l
females
units/l
patients
using emtricitabine-tenofovir df
clinical trials
significant decline in bmd
therapy-naive hiv
infected patients
using emtricitabine
tenofovir alafenamide with elvitegravir
cobicistat
virologically-suppressed tenofovir
df-treated patients
emtricitabine
tenofovir alafenamide with elvitegravir
cobicistat
bmd
baseline
week
bmd
rhabdomyolysis
osteomalacia
muscular weakness
myopathy
result of proximal renal tubulopathy
rhabdomyolysis
muscular weakness
myopathy
postmarketing experience with tenofovir df
emtricitabine-tenofovir df
increased creatine kinase
bone fractures-frequency
decreased bone mineral density
bmd
emtricitabine
tenofovir alafenamide
decreased bmd-uncommon
fractures
excluding fingers
toes
frequency
increased biochemical markers of bone metabolism
bmdemtricitabine
tenofovir df
myalgia
arthralgia
painemtricitabine
increased creatine kinase-common
myalgia
arthralgiatenofovir df
increased creatine kinase-common
myalgia
arthralgia
rhabdomyolysis
myopathy-frequency
decreased bmd
biochemical markers of bone
metabolism-postmarketing reports
osteomalacia
bone pain
fractures
combination
antiretroviral therapy
frequency
osteonecrosis
increased creatinine
uln
uln
emtricitabine-tenofovir df
trials in antiretroviral therapy-naive hiv
infected patients
median
estimated glomerular filtration rate
egfr
ml/min at baseline
using emtricitabine
tenofovir alafenamide with elvitegravir
cobicistat
serum creatinine
mg/dl from baseline
week
median upcr
mg/g at baseline
week in a trial in virologically-suppressed tenofovir
df-treated patients
egfr ml/min at baseline
emtricitabine
tenofovir alafenamide with elvitegravir
cobicistat
serum creatinine
baseline
median upcr
mg/g at baseline
mg/g at week in a trial in renal dysfunction patients
baseline egfr
ml/min
using emtricitabine
tenofovir alafenamide with elvitegravir
cobicistat
serum creatinine
mg/dl at baseline
week
median upcr
mg/g at baseline
mg/g at week
proximal renal tubulopathy
tenofovir df
crcl
patients
stopping
drug
rhabdomyolysis
osteomalacia
bone abnormalities
contributing
fractures
hypokalemia
muscular weakness
myopathy
hypophosphatemia
result of proximal renal tubulopathy
renal failure
acute renal failure
fanconi syndrome
proximal renal tubulopathy
creatinine
nephrogenic diabetes insipidus
acute tubular necrosis
postmarketing experience with tenofovir df
emtricitabine-tenofovir df
increased creatinineemtricitabine
tenofovir alafenamide
frequency
increased serum creatinine
urine
protein-to-creatinine ratio
upcr
worsening
worsening renal functiontenofovir df
increased creatinine-rare
renal failure
acute tubular necrosis
proximal renal tubulopathy
including
fanconi syndrome
nephrogenic diabetes insipidus-frequency
new onset
worsening
worsening renal impairment-postmarketing reports
renal insufficiency
interstitial nephritis
including
acute cases
tenofovir prodrugs
frequency
renal impairment
including
renal failure
fanconi syndrome
emtricitabine-tenofovir df
proteinuria
urethritis
urinary tract infection
hematuria
genital ulceration
anogenital warts-uncommon
proteinuria
glycosuriatenofovir df
glycosuria
proteinuria-postmarketing reports
polyuria
increased glycosuria
hematuria
red blood cells/high power field
emtricitabine-tenofovir df
proteinuria
postmarketing experience with tenofovir df
emtricitabine-tenofovir df
frequency
immune reconstitution/reactivation syndrome
autoimmune disorders in the setting of immune reconstitution
graves
disease
polymyositis
guillain-barre syndrome
emtricitabine
allergic reactiontenofovir df
postmarketing reports
allergic reaction
including angioedema
tenofovir df
frequency
higher serum
parathyroid hormone levels
side effects of truvada
fda
healthcare professional for medical advice
blisters under the skin
rash with flat lesions
small raised lesions on the skin
redness of the skin
skin rash
itching skin
hives
welts
spots
skin
blister
pimple
blindness
vision changes
burning of the face
mouth
burning
crawling
itching
numbness
prickling
pins
needles
tingling feelings in the hands
arms
feet
legs
chest pain
clumsiness or unsteadiness
sensation of pins
needles
sneezing
sore throat
stabbing pain
weakness in the hands
feet
stomach discomfort
agitation
bloating
cloudy urine
bone pain
chills
coma
confusion
constipation
convulsions or seizures
cough
darkened urine
decreased appetite
decreased frequency
amount of urine
depression
diarrhea
breathing
painful urination
difficulty with swallowing
dizziness
fast heartbeat
fast, shallow breathing
fever
general feeling of discomfort
headache
hostility
increase in the amount of urine
increased blood pressure
increased thirst
indigestion
irritability
lethargy
loss of appetite
side pain
muscle pain
cramping
muscle twitching
nausea
pains in the stomach
side
abdomen
radiating
back
puffiness
swelling of the eyelids
eyes
face
lips
tongue
rapid weight gain
sleepiness
stupor
sudden decrease in the amount of urine
swelling of the face
fingers
hands
lower legs
ankles
tightness in the chest
unusual tiredness
weakness
vomiting
weight gain
yellow eyes
skin
lack
loss of strength
passing of gas
weight loss
acid
sour stomach
back pain
belching
difficulty with moving
discouragement
feeling
heartburn
increased cough
joint pain
loss of interest
pleasure
muscle
cramping
muscle pain
stiffness
pain
runny nose
stomach upset
stuffy nose
sweating
swollen joints
tiredness
trouble concentrating
trouble sleeping